Insider · CIK 0001606244

Paya Carlos V

Reports to the SEC for 5 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001606244

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	PCVXVaxcyte, Inc.A Award	Director	AAward	+2,265 sh	—	—	6,856
2026-06-15	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.4K sh	—	—	11,389
2026-05-14	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+8,741 sh	—	—	28,323
2025-06-12	PCVXVaxcyte, Inc.A Award	Director	AAward	+3,041 sh	—	—	4,591
2025-06-12	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.4K sh	—	—	15,372
2025-05-15	COLLCOLLEGIUM PHARMACEUTICAL, INCA Award	Director	AAward	+19.6K sh	—	—	19,582
2024-12-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−7,250 sh	—	—	0
2024-12-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,250 sh	—	—	7,250
2024-12-06	PCVXVaxcyte, Inc.G Gift	Director	GGift	−2,500 sh	—	—	1,550
2024-12-06	PCVXVaxcyte, Inc.A Award	Director	AAward	+2,500 sh	—	—	5,625
2024-06-06	PCVXVaxcyte, Inc.A Award	Director	AAward	+1,550 sh	—	—	4,050
2024-06-06	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,250 sh	—	—	7,250
2023-11-09	PCVXVaxcyte, Inc.G Gift	Director	GGift	−3,125 sh	—	—	2,500
2023-11-09	PCVXVaxcyte, Inc.A Award	Director	AAward	+3,125 sh	—	—	3,125
2023-11-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−30K sh	—	—	0
2023-11-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+30K sh	—	—	30,000
2023-11-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−18.8K sh	—	—	0
2023-11-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+18.8K sh	—	—	18,750
2023-11-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)G Gift	Director	GGift	−15K sh	—	—	0
2023-11-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)G Gift	Director	GGift	+15K sh	—	—	15,000
2023-06-14	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+26.4K sh	—	—	126,844
2023-06-14	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+35.4K sh	—	—	35,380
2023-06-13	PCVXVaxcyte, Inc.A Award	Director	AAward	+2,500 sh	—	—	5,625
2023-06-13	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-06-15	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+30.9K sh	—	—	100,468
2022-06-15	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+42.6K sh	—	—	42,571
2022-06-01	PCVXVaxcyte, Inc.A Award	Director	AAward	+3,125 sh	—	—	3,125
2022-06-01	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.8K sh	—	—	18,750
2021-10-27	PCVXVaxcyte, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-05-25	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+10.3K sh	—	—	69,554
2021-05-25	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.4K sh	—	—	15,402
2021-03-23	LABSTANDARD BIOTOOLS INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	—	—	59,212
2021-03-23	LABSTANDARD BIOTOOLS INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	0
2021-03-12	Keenova Therapeutics plcS Sale	Director	SSale	−16.6K sh	$0.40	−$6,715.379	0
2020-06-23	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+13.4K sh	—	—	56,712
2020-06-23	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+21K sh	—	—	20,993
2020-05-13	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−14.7K sh	$2.96	−$43.6K	16,614
2020-03-23	LABSTANDARD BIOTOOLS INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,500 sh	—	—	43,343
2020-03-23	LABSTANDARD BIOTOOLS INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,500 sh	—	—	2,500
2019-06-03	LABSTANDARD BIOTOOLS INC.A Award	Director	AAward	+3,987 sh	—	—	40,843
2019-06-03	LABSTANDARD BIOTOOLS INC. · Stock Option (Right to Buy)A Award	Director	AAward	+6,796 sh	—	—	6,796
2019-05-22	Keenova Therapeutics plcA Award	Director	AAward	+31.3K sh	—	—	31,349
2019-04-02	IMMUNE DESIGN CORP.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−35.6K sh	$5.85	−$208K	0
2019-04-02	IMMUNE DESIGN CORP.Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−121K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−195K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−67.3K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−61.2K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−245K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−175K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−217K sh	—	—	0

Recent filings

Accepted (ET)
Jun 164
Paya Carlos V0001606244-26-000004
SEC(opens sec.gov)
May 184
Paya Carlos V0001606244-26-000002
SEC(opens sec.gov)
Jun 164
Paya Carlos V0001606244-25-000003
SEC(opens sec.gov)
May 194
Paya Carlos V0001062993-25-009804
SEC(opens sec.gov)
Dec 104
Paya Carlos V0001649094-24-000122
SEC(opens sec.gov)
Jun 104
Paya Carlos V0001649094-24-000009
SEC(opens sec.gov)
Nov 94
Paya Carlos V0001209191-23-054846
SEC(opens sec.gov)

Companies

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300

SAN CARLOS, CA, 94070